A plausible explanation is that JAKi may precipitate central or severe thrombotic events such as pulmonary embolism in susceptible patients, possibly through complex interactions between systemic inflammation, endothelial dysfunction, and coagulation pathways that are modulated by JAK-STAT signaling. This evidence concerns the gene SOAT1 and endothelial dysfunction.